Impact Ethics

NTE In Action

Françoise Baylis joins a panel-guided ethical and theological dialogue about how gene-editing technology (esp. CRISPR) is challenging our understanding of what it means to be human, and how humans act as stewards of God’s creation.
Article reports on Françoise Baylis being named to an international, multidisciplinary committee tasked to plan the Third International Summit on Human Genome Editing (07-09 Mar 2022, The Francis Crick Institute, London UK).
Françoise Baylis elected to new Governing Board tasked to provide scientific and strategic leadership to the International Science Council.
Françoise Baylis joins other panelists for a vaccine passport (recorded) town hall organized by the Health Association of African Canadians.
Françoise Baylis joins (recorded) panel discussion with other colleagues from the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing.
Françoise Baylis moderates round-table discussion. Register for event with Halifax Public Library, online (15 Jun 2021, 6:00PM - 7:30PM).

NTE In Print

Françoise Baylis publishes a blog on ethical issues regarding heritable human genome editing.
Françoise Baylis, Seema Mohapatra, and Natalie Kofler discuss concerns about the scientific, ethical, and practical risks associated with the broad use of COVID-19 vaccine credential programs, including racial discrimination and inequity at the hands of others.
Matthew Herder, Alexander C. Egilman, and Joseph S. Ross discuss Health Canada's release of clinical information, how use of the data to date appears low and why increased use of these data could be invaluable.
Françoise Baylis with colleagues from a WHO Expert Advisory Committee publish a global report for governance and oversight of human genome editing.
Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish recommendations on human genome editing.
Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish a position paper on human genome editing.